CBFβ is not required for the emergence of nascent HSCs but is essential for a subsequent step before their release from the AGM.
Introduction
Hematopoietic development is evolutionarily conserved among vertebrates. Similar to mammals, zebrafish embryos undertake sequential waves of hematopoiesis at distinct locations during embryonic development. The first wave is primitive hematopoiesis, in which erythroid progenitors arise from the posterior lateral mesoderm (PLM) and form at later stages the intermediate cell mass (ICM) where erythroblasts are produced 1 . In parallel, primitive myeloid progenitors originate from the anterior lateral mesoderm (ALM) and later differentiate into macrophages 2 . The second wave is definitive hematopoiesis with the generation of HSCs, which can differentiate to all definitive blood lineages 3, 4 .
Starting at 30 hours post fertilization (hpf) HSCs emerge from the hemogenic endothelium of the ventral wall of the dorsal aorta (DA) in the zebrafish equivalent of the AGM region. High-resolution imaging revealed a stereotyped cell behavior during which endothelial cells from the ventral DA bend into the sub-aortic space and trans-differentiate into HSCs 5, 6 . This dynamic process has been termed endothelial hematopoietic transition (EHT) 6 . The HSCs in the sub-aortic mesenchyme enter the circulation through the axial vein and colonize the caudal hematopoietic tissue (CHT), which is considered functionally analogous to the mammalian fetal liver 7, 8 . HSCs in the CHT give rise to erythroid and myeloid progenitors 5, 6, 8 and then migrate toward the definitive hematopoietic organs in adult fish, thymus and kidney 8 . Similar to the mouse, a transient population of erythro-myeloid progenitors (EMPs) originates within the posterior blood island (PBI) and sustains the initiation of the definitive hematopoietic wave in zebrafish 9 .
Core Binding Factor (CBF) is a heterodimeric DNA-binding complex that consists of a DNA-binding α -subunit, encoded in mammals by RUNX1, 2 or 3, and a non-DNA binding β -subunit, encoded by CBFB 10, 11 . RUNX1 and CBFβ, encoded by RUNX1 and CBFB respectively, are both required for the development of definitive hematopoiesis. Mice with targeted disruption of either Runx1 or Cbfb show essentially identical phenotypes with complete lack of definitive hematopoiesis and lethality between
For personal use only. on January 1, 2018. by guest www.bloodjournal.org From 4 embryonic days 11.5 and 13.5 [12] [13] [14] [15] . The observations suggest that RUNX1 and CBFβ function together in vivo, which is consistent with biochemical studies that RUNX1 and CBFβ form a heterodimer for binding DNA and regulating the expression of downstream target genes 16, 17 . The absence of all definitive hematopoietic lineages in both Runx1 -/-and Cbfb -/-embryos also suggests that both genes are required at the stage of HSC specification. Subsequent studies demonstrated that Runx1 is required for the emergence of HSCs from the hemogenic endothelium within the AGM region in the mouse 18, 19 .
Our group previously generated a zebrafish runx1 mutant with a nonsense mutation (W84X) within the RUNT domain, resulting in a prematurely truncated RUNX1 protein. Homozygous runx1
mutants lack expression of the HSC marker c-myb and do not develop definitive blood lineages in the CHT and thymus 20, 21 . Further studies from other groups demonstrated that, in zebrafish, runx1 is also required for the emergence of HSCs from the hemogenic endothelium in the AGM 6 .
On the other hand, relatively little is known about the exact role of Cbfb during the early stages of HSC development in the mouse 22 , although it is assumed that Cbfb plays a similar role as Runx1 does. Even though a highly conserved cbfb gene (the encoded protein is 87% identical to the mammalian CBFβ proteins) has been identified in the zebrafish 23 , the role of the zebrafish cbfb during HSC production in definitive hematopoiesis remains to be investigated.
In this study we generated and characterized two independent zebrafish cbfb knockout mutant lines (cbfb -/-), which revealed a previously unknown role of cbfb during definitive hematopoiesis and showed that the function of RUNX1 and CBFβ during HSC development could be uncoupled.
For
Methods

Zebrafish lines and maintenance
Zebrafish were maintained and used following approved National Human Genome Research Institute Animal Care and Use Committee protocols. Zebrafish handling and breedings were performed as described 24 . The following strains were used: wild type EK (Ekkwill), runx1 W84X 21 , tg(c-myb:eGFP) 25 , tg(cd41:GFP) 26 , tg(flk1:moesin1-eGFP) 27 . The mind bomb ta52b mutant line 28 , the transgenic line tg(uas:NICD) and tg(hsp70:gal4) 29 were kindly provided by Ajay Chitnis.
Generation of cbfb mutants and genotyping
Sixteen pairs of CompoZr ZFNs targeting the first half of the open reading frame of the cbfb gene were designed and evaluated for in vitro activity by Sigma-Aldrich (St. Louis, MO) and mRNA from the pair with the highest in vitro activity was chosen for subsequent targeted mutagenesis. Injection of mRNA, founder screening and identification of cbfb heterozygous adult fish has been described in detail previously 30 .
For each experiment cbfb-Del4 and cbfb-Ins4 were genotyped by fluorescent PCR using a mixture of M13F-tailed (5'-TGTAAAACGACGGCCAGT-3') cbfb-specific forward primer (5'-ATGCTCGGGCCTGGCTTTCT-3'), 6-FAM labeled M13F primer and PIGtailed (5'-GTGTCTT-3') cbfb-specific reverse primer (5'-AGGGGCGTGAGTTAGAGT-3') in the PCR mix 30 . Genotyping of fixed samples has been performed as above but using a different PCR mix (Sigma RED Extract-N-Amp ™ PCR Ready Mix R4775). Significance and standard deviation between samples were calculated using Excel (Microsoft).
Ro5-3335 treatment
Two zebrafish embryos at 22 hpf were placed into each well of 96-well plates (Costar #3635). These embryos were then incubated with Ro5-3335 at 5 μM, 2.5 μM, 0.5 μM and 0.25 μM in E3 embryo medium (32-48 embryos per treatment in a final volume of 300 μl per well). As a control embryos were treated with 0.1% DMSO in E3 embryo medium. Embryos were treated from 24 hpf to 36 hpf, or from 24 hpf to 3 days post fertilization (dpf), then fixed with 4% PFA and processed for in situ hybridization for cmyb or runx1 expression.
Heat shock treatment of NICD transgenic embryos
The transgenic line tg(uas:NICD) was crossed to tg(hsp70:gal4). Embryos between 8-12-somite stages were collected in 50-ml Falcon tubes and were heat shocked for 30 minutes in a 37°C water bath. After the heat shock, the embryos were placed in Petri dishes, allowed to develop until 36-40 hpf and then fixed in 4% PFA. Fixed embryos were then processed for in situ hybridization for c-myb, runx1 or cbfb expression. 
Results
Generation of zebrafish cbfb -/-mutants
To determine the role of CBFβ in the formation of HSCs we generated two independent cbfb mutant lines by zinc-finger nuclease (ZFN) -mediated targeted mutagenesis 32, 33 . The selected CompoZr ZFN pair targeted a specific region within cbfb exon 3 (Fig. 1A ) 30 .
Among nine mutations identified 30 
Loss of cbfb does not affect primitive hematopoiesis and EMP formation
In a previous report, we showed that in WT embryos cbfb expression is detectable suggesting that primitive myeloid cells were unaffected. In addition, cbfb null embryos had normal expression of gata1, l-plastin and mpx in the PBI at 36 hpf, indicating that the EMP progenitors were correctly specified (Supplemental Fig. 2A-I ).
The zebrafish cbfb -/-embryos lack definitive hematopoiesis
It is known that loss of either Runx1 or Cbfb abolishes the onset and the development of definitive hematopoietic cells in mouse embryos 12, 13 . Since the zebrafish runx1
mutant embryos also lack definitive hematopoiesis 21 , we evaluated the presence of definitive blood lineages in the cbfb -/-mutants ( Fig. 2 and Supplemental Fig. 3 ). At 3 dpf, the expression of l-plastin in definitive myeloid progenitors within the CHT was almost Fig. 2A and Supplemental Fig. 3A ). The expression of hbae1 in erythroid precursors within the CHT was also abrogated in cbfb del4/del4 ( Fig. 2C and D) and cbfb ins4/ins4 (Supplemental Fig. 3C and D) embryos at 6 dpf. The lymphoid markers ikaros and rag1 in the developing thymus were absent in cbfb del4/del4 (Fig. 2E-H) and cbfb ins4/ins4 (Supplemental Fig. 3E-H However, at 36 hpf c-myb expression was observed along the ventral wall of the DA in both cbfb del4/del4 (Fig. 3B, B' ) and cbfb ins4/ins4 (Fig. 3C , C') embryos at similar levels to their WT clutchmates (Fig. 3A, A' ). Similarly, expression of the early HSC marker, runx1, was intact or even slightly increased in the ventral DA region of the cbfb del4/del4
( Fig. 3E , E') and cbfb ins4/ins4 (Fig. 3F, F' ) embryos at 36 hpf, as compared to the controls (Fig. 3D, D' ). Given the normal expression of c-myb and the strong expression of runx1
in cbfb -/-mutants at 36 hpf, we evaluated the presence of a compensatory mechanism involving other runx family members. However, in cbfb -/-embryos between 36 hpf and 
HSCs do not reach CHT and kidney in the cbfb -/-embryos
Starting from 30 hpf HSCs asynchronously egress from the ventral DA into the sub-aortic space and intravasate into the axial vein to seed the CHT 7 . Consistent with the translocation of HSCs, at 2 dpf c-myb expression is observed in both AGM and CHT regions of wild type embryos ( Fig. 4A and A' ). However, c-myb expression in cbfb -/-mutants appeared strongly reduced and was detectable only in the AGM (Fig. 4B, B' , C, C'). At 3 dpf, when c-myb + cells were found only in the CHT of wild type embryos ( 
siblings at 36 and 48 hpf did not show differences in proliferation of the hematopoietic progenitors (eGFP + cells) within the AGM (Supplemental Fig. 4C-F) .
On the other hand, the expression of the early HSC marker, runx1, was maintained in the AGM of cbfb -/-mutants (Fig. 5B, B' , C, C') at 48 hpf as compared to the wild type embryos (Fig. 5A, A' ). In WT embryos at 3 dpf HSCs were located in the CHT and runx1 expression was no longer detectable in the AGM (Fig. 5D and D' ). embryo (n=5) in the same recorded period (Fig. 5J) , which was significantly lower than the control (p<0.001).
Thus, unlike runx1 W84X/W84X mutants where HSC formation was completely abrogated, nascent HSCs were formed in the cbfb -/-embryos but they could not leave the AGM.
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Pharmacological inhibition of RUNX1-CBFβ interaction phenocopies the hematopoietic defects in cbfb -/-embryos
Recently we identified a specific inhibitor of the RUNX1-CBFβ interaction, Ro5-3335 37 .
Zebrafish embryos treated with Ro5-3335 from 24 hpf to 6 dpf showed defects in the the CHT region at 3 dpf, similar to the phenotype in the cbfb -/-embryos (Fig. 6B ). In addition, cbfb +/del4 mutants were more sensitive to Ro5-3335 treatment than WT embryos for the absence of c-myb expression in CHT, as more cbfb +/del4 embryos developed the phenotype than WT embryos at a given concentration (compare Fig. 6B with Supplemental Fig. 5E ).
To confirm that Ro5-3335 fully recapitulated the cbfb -/-mutant hematopoietic phenotype, Taken together our results showed that treatments with the RUNX1-CBFβ inhibitor Ro5-3335 phenocopied the phenotype observed in cbfb -/-mutants and confirmed that the function of RUNX1 and CBFβ during HSC development could be uncoupled.
cbfb acts downstream of the Notch pathway
The Notch-Runx1 pathway is critical for the initial specification of HSCs during definitive hematopoiesis 34, 38 . . Based on these observations we evaluated whether cbfb was also controlled by Notch activity. We confirmed that 36 hpf mind bomb mutants lacked the expression of cmyb and runx1 in the artery (data not shown). Interestingly, we observed that cbfb expression within the hematopoietic progenitors in the ventral wall of the DA was also abolished in 36 hpf mind bomb mutants (Fig. 7A, A', B, B' ). We then examined the expression of c-myb, runx1 and cbfb by WISH in 36 hpf hsp70:gal4;uas:NICD embryos, which were heat shocked between 8 and 12 somites. We confirmed that the expression of c-myb and runx1 was expanded in the heat-shocked embryos (Fig. 7C-F' ). We observed that cbfb expression was also expanded in the aorta and ectopically expressed in the vein (Fig. 7G, G' , H, H'), similar to both c-myb and runx1 (Fig. 7C-F' ). These results suggest that cbfb expression is regulated by Notch activity. 
Discussion
The Cbfb gene has been demonstrated as a key regulator of definitive hematopoiesis during embryogenesis in mice 12, 15 . Cbfb -/-embryos lacked definitive hematopoiesis, while some EMPs remained 15 . In a recent study, lineage specific expression of a Cbfb transgene in Cbfb knockout mice showed that EMPs and HSCs differentiate from distinct populations of hemogenic endothelial cells 22 . However, there have been no reported studies on the exact roles of Cbfb for the emergence of HSCs from hemogenic endothelium.
In this study we generated two independent zebrafish cbfb knockout mutants (cbfb -/-), which presented identical hematopoietic phenotypes. cbfb -/-embryos retained primitive hematopoiesis and EMPs but completely lacked all definitive blood lineages. Studies in both mouse and zebrafish clearly demonstrated that Runx1 is required for the endothelialhematopoietic transition (EHT) of the hemogenic endothelium into HSC during the early phases of definitive hematopoiesis 6, 18, 19 . Therefore, since CBFβ is considered the obligate partner of RUNX1, the impairment of all definitive hematopoietic lineages in both
Runx1
-/-and Cbfb -/-mice suggested that the CBF heterodimer is required for HSC formation. Our present data, however, suggest that runx1 and cbfb are required at different steps during the early formation of HSCs. Indeed, the emergence of the nascent, 
treatments, even at relatively high doses. Moreover, neither cbfb +/del4 nor runx1
embryos showed a reduction in c-myb expression within the DA after Ro5-3335 treatment. The presence of nascent runx1 + /c-myb + HSCs does not appear to be due to compensatory mechanism driven by other runx family members as their expression in cbfb -/-mutants was normal. We can also exclude any contribution from maternal cbfb mRNA as cbfb expression is only zygotic 23 . Overall, the emergence of nascent HSCs from the hemogenic endothelium in the absence of cbfb or a functional CBF complex indicate that CBFβ is not necessary for the EHT and strongly suggests that the function of RUNX1 and CBFβ during HSC development can be uncoupled. In the future, the temporal requirement of CBFβ during HSC development can be defined more precisely by treating the embryos with Ro5-3335 within different time windows.
Interestingly, we found that c-myb expression in the HSCs was progressively lost and no c-myb + cell colonizes the CHT region of the cbfb -/-embryos at 3 dpf. Similarly, treatments of wild type embryos with Ro5-3335 resulted in a dose-dependent reduction of c-myb expression in the CHT region. We confirmed that this phenotype resulted from the specific inhibition of the RUNX1-CBFβ interaction by showing that cbfb +/del4 mutants were more sensitive to Ro5-3335 treatment than WT embryos.
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